Home › Funds › Duquesne Family Office LLC › RLAY

Duquesne Family Office LLC position in RLAY

RELAY THERAPEUTICS INC · Health Care

Duquesne Family Office LLC reported holding 852,600 shares of RLAY (RELAY THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$15.4M, representing 0.41% of its reported portfolio and ranking #41 among its reported holdings. Duquesne Family Office LLC has disclosed RLAY holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)852.60K sh
Reported value held$15.39M
Portfolio Weight0.41%
First reportedQ2 2026
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Duquesne Family Office LLC's RLAY position evolved

Duquesne Family Office LLC first disclosed a stake in RLAY in Q2 2026 at 349,000 shares (US$6.5M). The position peaked in Q3 2026 at 852,600 shares, worth US$15.4M. Across 2 filings, Duquesne Family Office LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 852,600 shares valued at US$15.4M — an increase of 503,600 shares quarter over quarter.. Notable position changes include a 144% increase in Q3 2026 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 349.00K $6.53M New
Q3 2026 852.60K $15.39M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RLAY and 13F data

RLAY (RELAY THERAPEUTICS INC) is a Health Care company. 55 other funds we track also report a position in RLAY — the largest reported positions include SB INVESTMENT ADVISERS (UK) LTD (US$522.1M), Casdin Capital (US$289.4M), PERCEPTIVE ADVISORS LLC (US$229.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RLAY

All RLAY fund holders →

FAQ

How long has Duquesne Family Office LLC held RLAY?

Duquesne Family Office LLC has disclosed RLAY holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Duquesne Family Office LLC's current position in RLAY?

As of Q3 2026, Duquesne Family Office LLC holds 852.60K shares of RLAY (RELAY THERAPEUTICS INC), valued at $15.39M, representing 0.41% of its reported portfolio and ranking #41.

Has Duquesne Family Office LLC been buying or selling RLAY?

In the latest 13F filing (Q3 2026), Duquesne Family Office LLC increased its position in RLAY. The position peaked in Q3 2026 at 852.60K shares.

Which other funds hold RLAY?

Other major institutional holders of RLAY include SB INVESTMENT ADVISERS (UK) LTD, Casdin Capital, PERCEPTIVE ADVISORS LLC, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.